<table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="tbl6" position="float"><object-id pub-id-type="doi">10.7554/eLife.18082.013</object-id><label>Table 6.</label><caption><p>Antibiogram of <italic>P. aeruginosa</italic> causing bacteraemia in Northeast Thailand.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.18082.013">http://dx.doi.org/10.7554/eLife.18082.013</ext-link></p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top">Antibiotic category</th><th valign="top">Antibiotic agents</th><th valign="top">CAB <break/>(n&#160;=&#160;286 patients)</th><th valign="top">HCAB <break/>(n&#160;=&#160;103 patients)</th><th valign="top">HAB <break/>(n&#160;=&#160;179 patients)</th><th valign="top">p values</th></tr></thead><tbody><tr><td rowspan="4" valign="top">Aminoglycosides</td><td valign="top">Gentamicin</td><td valign="top">29/235 (12%)</td><td valign="top">13/88 (15%)</td><td valign="top">60/140 (43%)</td><td valign="top">&lt;0.001</td></tr><tr><td valign="top">Tobramycin</td><td valign="top">NA</td><td valign="top">NA</td><td valign="top">NA</td><td valign="top">-</td></tr><tr><td valign="top">Amikacin</td><td valign="top">27/284 (10%)</td><td valign="top">13/100 (13%)</td><td valign="top">48/177 (27%)</td><td valign="top">&lt;0.001</td></tr><tr><td valign="top">Netilmicin</td><td valign="top">8/155 (5%)</td><td valign="top">5/67 (7%)</td><td valign="top">34/120 (28%)</td><td valign="top">&lt;0.001</td></tr><tr><td rowspan="3" valign="top">Antipseudomonal carbapenems</td><td valign="top">Imipenem</td><td valign="top">14/238 (6%)</td><td valign="top">6/86 (7%)</td><td valign="top">37/154 (24%)</td><td valign="top">&lt;0.001</td></tr><tr><td valign="top">Meropenem</td><td valign="top">9/163 (6%)</td><td valign="top">8/73 (11%)</td><td valign="top">24/125 (19%)</td><td valign="top">0.001</td></tr><tr><td valign="top">Doripenem</td><td valign="top">2/17 (12%)</td><td valign="top">0/3 (0%)</td><td valign="top">2/2 (100%)</td><td valign="top">0.04</td></tr><tr><td rowspan="2" valign="top">Antipseudomonal cephalosporins</td><td valign="top">Ceftazidime</td><td valign="top">29/280 (10%)</td><td valign="top">16/103 (16%)</td><td valign="top">68/179 (38%)</td><td valign="top">&lt;0.001</td></tr><tr><td valign="top">Cefepime</td><td valign="top">2/36 (6%)</td><td valign="top">2/18 (11%)</td><td valign="top">10/28 (36%)</td><td valign="top">0.01</td></tr><tr><td rowspan="2" valign="top">Antipseudomonal fluoroquinolones</td><td valign="top">Ciprofloxacin</td><td valign="top">24/275 (9%)</td><td valign="top">12/101 (12%)</td><td valign="top">39/169 (23%)</td><td valign="top">&lt;0.001</td></tr><tr><td valign="top">Levofloxacin</td><td valign="top">0/1 (0%)</td><td valign="top">1/1 (100%)</td><td valign="top">1/1 (100%)</td><td valign="top">&gt;0.99</td></tr><tr><td rowspan="2" valign="top">Antipseudomonal penicillins + &#946; lactamase inhibitors</td><td valign="top">Ticarcillin-clauvanic acid</td><td valign="top">NA</td><td valign="top">NA</td><td valign="top">NA</td><td valign="top">-</td></tr><tr><td valign="top">Piperacillin-tazobactam</td><td valign="top">8/85 (9%)</td><td valign="top">6/38 (16%)</td><td valign="top">8/46 (17%)</td><td valign="top">0.37</td></tr><tr><td valign="top">Monobactams</td><td valign="top">Aztreonam</td><td valign="top">NA</td><td valign="top">NA</td><td valign="top">NA</td><td valign="top">-</td></tr><tr><td valign="top">Phosphonic acids</td><td valign="top">Fosfomycin</td><td valign="top">1/1 (100%)</td><td valign="top">NA</td><td valign="top">NA</td><td valign="top">-</td></tr><tr><td valign="top">Polymyxins</td><td valign="top">Colistin</td><td valign="top">0/7 (0%)</td><td valign="top">0/3 (0%)</td><td valign="top">1/7 (14%)</td><td valign="top">&gt;0.99</td></tr><tr><td valign="top"/><td valign="top">Polymyxin B</td><td valign="top">NA</td><td valign="top">NA</td><td valign="top">NA</td><td valign="top">-</td></tr><tr><td valign="top">MDR</td><td valign="top"/><td valign="top">13/286 (5%)</td><td valign="top">10/103 (10%)</td><td valign="top">45/179 (25%)</td><td valign="top">&lt;0.001</td></tr></tbody></table><table-wrap-foot><fn id="tblfn11"><p>NOTE: Data are number of isolates demonstrating non-susceptible to the antimicrobial over the total number of isolates tested (%). CAB&#160;=&#160;Community-acquired bacteraemia, HCAB&#160;=&#160;Healthcare-associated bacteraemia, HAB&#160;= Hospital-acquired bacteraemia, and NA&#160;=&#160;Not available. The first isolate of each patient was used. MDR: non-susceptible to &#8805;1 agent in &#8805;3 antimicrobial categories.</p></fn></table-wrap-foot></table-wrap>